Basic Information
AnTolRx Addresses Significant Unmet Needs in Autoimmunity by Developing Novel Proprietary Therapies for Disease Treatment. Our Platform Approach Involves Creating New Targeted Therapies That Leverage Specific Autoantigens and Unique Tolerogenic Molecules to Actively Promote Immune Tolerance. Our Patented Nanotechnology is Designed to Induce Antigen-Specific Immune Tolerance.
AnTolRx, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2015
info@antolrx.com

